with the most potent topical steroids in Class 1 and the least potent in Class 7 (see Table 4). Longer duration of therapy and more potent topical steroids have a higher potential for adverse effects.

The US Food and Drug Administration (FDA) has approved Galderma's monoclonal antibody, Nemluvio (nemolizumab), for ...

KKH and the National Skin Centre say there are more such patients, but no recent studies have been done. Read more at ...

We are looking for Directors with experience in Business Development and Strategy, Public Relations, Legal and Non-profit Governance, Policy, and Conflict Resolution to help address the emerging ...

Te Rima Whakatau experienced symptoms of topical steroid withdrawal after his eczema was treated with steroid creams. Photos / Te Rima Whakatau An Auckland-based artist living with debilitating ...

The prevalence of eczema in Singapore has been largely stable in the past decade, affecting about one in five children and ...

First in class In May, the U.S. Food and Drug Administration approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist and the first FDA-approved steroid-free topical medication in ...

The Skin Salvation balm from Balmonds has been hailed as a 'saviour' by customers who have suffered from dry, itchy skin, ...

Balmonds' Skin Salvation balm has been praised by dermatologists and customers for its ability to transform dry, itchy and ...

Shares in Galderma climbed after the company said the U.S. Food and Drug Administration approved its drug Nemluvio for the treatment of patients with atopic dermatitis. Shares in Galderma were 3.2% ...